Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
Stock
BIIB
BIIB News & Events
-
Add to Watchlist
Trade BIIB Autonomously
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Stock Price Prediction
Technical
Valuation
Financials
Earnings
Should I Buy
News & Events
BIIB News
Biogen Acquires RayThera to Strengthen Immunology Business
3d ago
Fool
Biogen Acquires RayThera for $1 Billion to Boost Immunology Business
3d ago
Yahoo Finance
Biogen's Diversified Strategy and Investment Opportunities
5d ago
stocktwits
Investment Opportunities in Biotech Stocks
5d ago
CNBC
Biogen Warns of Q2 Financial Impact from Acquisitions
5d ago
seekingalpha
Software Stocks Rally as Moderna Surges 11% on Long-Term Strategy
Jun 26 2026
CNBC
Biogen Under Investigation for Securities Fraud Claims
Jun 23 2026
Globenewswire
NeOnc Secures Abu Dhabi IND Authorization for NEO212
Jun 22 2026
Newsfilter
Show More News
BIIB Events
No data
BIIB Monitor News
Biogen faces investigation amid disappointing trial results
Jun 26 2026
Biogen Completes Acquisition of Apellis Pharmaceuticals
May 14 2026
FDA Extends LEQEMBI Review Period, Impacting Biogen's Market Strategy
May 13 2026
Biogen Reports Strong Q1 Earnings but Lowers Full-Year Outlook
Apr 29 2026
Biogen anticipates Q1 EPS impact due to R&D charges
Apr 06 2026
Biogen's High Dose SPINRAZA Approved for SMA Treatment
Mar 31 2026
Biogen Reports Strong Q4 Earnings and Positive Nusinersen Study Results
Feb 06 2026
Biogen's High-Dose Nusinersen Shows Promise in SMA Treatment
Feb 04 2026
Show More Monitor News
BIIB Earnings Analysis
Biogen Reports Third Quarter Financial Results
1 years ago
People Also Watch
